000 01499 a2200433 4500
005 20250514070342.0
264 0 _c20031007
008 200310s 0 0 eng d
022 _a0903-1936
024 7 _a10.1183/09031936.03.00065102
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLabiris, N R
245 0 0 _aUptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?
_h[electronic resource]
260 _bThe European respiratory journal
_cMay 2003
300 _a848-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAminoglycosides
_xtherapeutic use
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aFemale
650 0 4 _aFluorodeoxyglucose F18
_xpharmacokinetics
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutrophil Activation
650 0 4 _aPneumonia
_xdiagnostic imaging
650 0 4 _aRadiopharmaceuticals
_xpharmacokinetics
650 0 4 _aSputum
_xcytology
650 0 4 _aTobramycin
_xtherapeutic use
650 0 4 _aTomography, Emission-Computed
_xmethods
700 1 _aNahmias, C
700 1 _aFreitag, A P
700 1 _aThompson, M L
700 1 _aDolovich, M B
773 0 _tThe European respiratory journal
_gvol. 21
_gno. 5
_gp. 848-54
856 4 0 _uhttps://doi.org/10.1183/09031936.03.00065102
_zAvailable from publisher's website
999 _c12551967
_d12551967